Abstract
DNA cytosine methylation is a central epigenetic modification that has essential roles in cellular processes including genome regulation, development and disease. Here we present the first genome-wide, single-base-resolution maps of methylated cytosines in a mammalian genome, from both human embryonic stem cells and fetal fibroblasts, along with comparative analysis of messenger RNA and small RNA components of the transcriptome, several histone modifications, and sites of DNA–protein interaction for several key regulatory factors. Widespread differences were identified in the composition and patterning of cytosine methylation between the two genomes. Nearly one-quarter of all methylation identified in embryonic stem cells was in a non-CG context, suggesting that embryonic stem cells may use different methylation mechanisms to affect gene regulation. Methylation in non-CG contexts showed enrichment in gene bodies and depletion in protein binding sites and enhancers. Non-CG methylation disappeared upon induced differentiation of the embryonic stem cells, and was restored in induced pluripotent stem cells. We identified hundreds of differentially methylated regions proximal to genes involved in pluripotency and differentiation, and widespread reduced methylation levels in fibroblasts associated with lower transcriptional activity. These reference epigenomes provide a foundation for future studies exploring this key epigenetic modification in human disease and development.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
£199.00 per year
only £3.90 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Accession codes
Primary accessions
Gene Expression Omnibus
Data deposits
Sequence data is available under the GEO accessions GSM429321-23, GSM432685-92, GSM438361-64, GSE17917, GSE18292 and GSE16256, and the SRA accessions SRX006782-89, SRX006239-41, SRX007165.1-68.1 and SRP000941. Analysed data sets can be obtained from http://neomorph.salk.edu/human_methylome.
References
Holliday, R. & Pugh, J. E. DNA modification mechanisms and gene activity during development. Science 187, 226–232 (1975)
Riggs, A. D. X inactivation, differentiation, and DNA methylation. Cytogenet. Cell Genet. 14, 9–25 (1975)
Bestor, T. H. The DNA methyltransferases of mammals. Hum. Mol. Genet. 9, 2395–2402 (2000)
Li, E., Bestor, T. H. & Jaenisch, R. Targeted mutation of the DNA methyltransferase gene results in embryonic lethality. Cell 69, 915–926 (1992)
Lippman, Z. et al. Role of transposable elements in heterochromatin and epigenetic control. Nature 430, 471–476 (2004)
Okano, M., Bell, D. W., Haber, D. A. & Li, E. DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell 99, 247–257 (1999)
Reik, W. Stability and flexibility of epigenetic gene regulation in mammalian development. Nature 447, 425–432 (2007)
Straussman, R. et al. Developmental programming of CpG island methylation profiles in the human genome. Nature Struct. Mol. Biol. 16, 564–571 (2009)
Weber, M. & Schübeler, D. Genomic patterns of DNA methylation: targets and function of an epigenetic mark. Curr. Opin. Cell Biol. 19, 273–280 (2007)
Cedar, H. & Bergman, Y. Linking DNA methylation and histone modification: patterns and paradigms. Nature Rev. Genet. 10, 295–304 (2009)
Rauch, T. A., Wu, X., Zhong, X., Riggs, A. D. & Pfeifer, G. P. A human B cell methylome at 100-base pair resolution. Proc. Natl Acad. Sci. USA 106, 671–678 (2009)
Ball, M. et al. Targeted and genome-scale strategies reveal gene-body methylation signatures in human cells. Nature Biotechnol. 27, 361–368 (2009)
Deng, J. et al. Targeted bisulfite sequencing reveals changes in DNA methylation associated with nuclear reprogramming. Nature Biotechnol. 27, 353–360 (2009)
Meissner, A. et al. Genome-scale DNA methylation maps of pluripotent and differentiated cells. Nature 454, 766–770 (2008)
Lister, R. et al. Highly integrated single-base resolution maps of the epigenome in Arabidopsis . Cell 133, 523–536 (2008)
Cokus, S. J. et al. Shotgun bisulphite sequencing of the Arabidopsis genome reveals DNA methylation patterning. Nature 452, 215–219 (2008)
Thomson, J. A. et al. Embryonic stem cell lines derived from human blastocysts. Science 282, 1145–1147 (1998)
Nichols, W. W. et al. Characterization of a new human diploid cell strain, IMR-90. Science 196, 60–63 (1977)
Ramsahoye, B. H. et al. Non-CpG methylation is prevalent in embryonic stem cells and may be mediated by DNA methyltransferase 3a. Proc. Natl Acad. Sci. USA 97, 5237–5242 (2000)
Woodcock, D. M., Crowther, P. J. & Diver, W. P. The majority of methylated deoxycytidines in human DNA are not in the CpG dinucleotide. Biochem. Biophys. Res. Commun. 145, 888–894 (1987)
Aoki, A. et al. Enzymatic properties of de novo-type mouse DNA (cytosine-5) methyltransferases. Nucleic Acids Res. 29, 3506–3512 (2001)
Gowher, H. & Jeltsch, A. Enzymatic properties of recombinant Dnmt3a DNA methyltransferase from mouse: the enzyme modifies DNA in a non-processive manner and also methylates non-CpA sites. J. Mol. Biol. 309, 1201–1208 (2001)
Gonzalo, S. et al. DNA methyltransferases control telomere length and telomere recombination in mammalian cells. Nature Cell Biol. 8, 416–424 (2006)
Steinert, S., Shay, J. W. & Wright, W. E. Modification of subtelomeric DNA. Mol. Cell. Biol. 24, 4571–4580 (2004)
Brunner, A. L. et al. Distinct DNA methylation patterns characterize differentiated human embryonic stem cells and developing human fetal liver. Genome Res. 19, 1044–1056 (2009)
Ferguson-Smith, A. C. & Greally, J. Epigenetics: perceptive enzymes. Nature 449, 148–149 (2007)
Jia, D., Jurkowska, R. Z., Zhang, X., Jeltsch, A. & Cheng, X. Structure of Dnmt3a bound to Dnmt3L suggests a model for de novo DNA methylation. Nature 449, 248–251 (2007)
Bell, A. C. & Felsenfeld, G. Methylation of a CTCF-dependent boundary controls imprinted expression of the Igf2 gene. Nature 405, 482–485 (2000)
Clark, S. J., Harrison, J. & Molloy, P. L. Sp1 binding is inhibited by (m)Cp(m)CpG methylation. Gene 195, 67–71 (1997)
Hark, A. T. et al. CTCF mediates methylation-sensitive enhancer-blocking activity at the H19/Igf2 locus. Nature 405, 486–489 (2000)
Kitazawa, S., Kitazawa, R. & Maeda, S. Transcriptional regulation of rat cyclin D1 gene by CpG methylation status in promoter region. J. Biol. Chem. 274, 28787–28793 (1999)
Mancini, D. N., Singh, S. M., Archer, T. K. & Rodenhiser, D. I. Site-specific DNA methylation in the neurofibromatosis (NF1) promoter interferes with binding of CREB and SP1 transcription factors. Oncogene 18, 4108–4119 (1999)
Johnson, D. S., Mortazavi, A., Myers, R. M. & Wold, B. Genome-wide mapping of in vivo protein-DNA interactions. Science 316, 1497–1502 (2007)
Heintzman, N. et al. Histone modifications at human enhancers reflect global cell-type-specific gene expression. Nature 459, 108–112 (2009)
Schmidl, C. et al. Lineage-specific DNA methylation in T cells correlates with histone methylation and enhancer activity. Genome Res. 19, 1165–1174 (2009)
Johnson, L. M. et al. The SRA methyl-cytosine-binding domain links DNA and histone methylation. Curr. Biol. 17, 379–384 (2007)
Jones, P. A. & Baylin, S. B. The epigenomics of cancer. Cell 128, 683–692 (2007)
Hellman, A. & Chess, A. Gene body-specific methylation on the active X chromosome. Science 315, 1141–1143 (2007)
The International Stem Cell Initiative Characterization of human embryonic stem cell lines by the International Stem Cell Initiative. Nature Biotechnol. 25, 803–816 (2007)
Villesen, P., Aagaard, L., Wiuf, C. & Pedersen, F. S. Identification of endogenous retroviral reading frames in the human genome. Retrovirology 1, 32 (2004)
Chan, S. W. Inputs and outputs for chromatin-targeted RNAi. Trends Plant Sci. 13, 383–389 (2008)
Azuara, V. et al. Chromatin signatures of pluripotent cell lines. Nature Cell Biol. 8, 532–538 (2006)
Bernstein, B. E. et al. A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell 125, 315–326 (2006)
Ludwig, T. et al. Feeder-independent culture of human embryonic stem cells. Nature Methods 3, 637–646 (2006)
Ludwig, T. et al. Derivation of human embryonic stem cells in defined conditions. Nature Biotechnol. 24, 185–187 (2006)
Langmead, B., Trapnell, C., Pop, M. & Salzberg, S. L. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol. 10, R25 (2009)
Acknowledgements
We thank A. Elwell and A. Hernandez for assistance with sequence library preparation and Illumina sequencing. R.L. is supported by a Human Frontier Science Program Long-term Fellowship. R.D.H. is supported by an American Cancer Society Postdoctoral Fellowship. This work was supported by grants from the following: Mary K. Chapman Foundation, The National Institutes of Health (U01 ES017166 and U01 1U01ES017166-01), the California Institute for Regenerative Medicine (RS1-00292-1), the Australian Research Council Centre of Excellence Program (CE0561495, DP0771156) and Morgridge Institute for Research, Madison, Wisconsin. We thank the NIH Roadmap Reference Epigenome Consortium (http://nihroadmap.nih.gov/epigenomics/referenceepigenomeconsortium.asp) and C. Gunter (Hudson-Alpha Institute) for assistance. This study was carried out as part of the NIH Roadmap Epigenomics Program.
Author Contributions Experiments were designed by J.R.E., B.R., R.L., J.A.T. and R.D.H. Cells were grown by J.A.-B. and Q.-M.N. MethylC-Seq, RNA-Seq and smRNA-Seq experiments were conducted by R.L. and J.R.N. ChIP-Seq experiments were conducted by R.D.H., L.L. and Z.Y. ChIP-Seq data analysis was performed by G.H., R.D.H. and L.E. BS-PCR validation was performed by R.H.D. Sequencing data processing was performed by R.L., J.T.-F., L.E., V.R. and G.H. Bioinformatic and statistical analyses were conducted by M.P., R.L., G.H., J.T.-F., R.H.D., R.S. and A.H.M. AnnoJ development was performed by J.T.F and A.H.M. The manuscript was prepared by R.L., M.P., R.H.D., A.H.M. and J.R.E.
Author information
Authors and Affiliations
Corresponding author
Supplementary information
Supplementary Information
This file contains Supplementary Figures 1-16 with Legends, Supplementary Methods, Supplementary Data and Supplementary References. (PDF 5433 kb)
Supplementary Tables
This file contains Supplementary Tables 1-12 which provide additional material that is referred to in the main article. (XLS 3523 kb)
Rights and permissions
About this article
Cite this article
Lister, R., Pelizzola, M., Dowen, R. et al. Human DNA methylomes at base resolution show widespread epigenomic differences . Nature 462, 315–322 (2009). https://doi.org/10.1038/nature08514
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/nature08514
This article is cited by
-
Identification of DNA methylation biomarkers for evaluating cardiovascular disease risk from epigenome profiles altered by low-dose ionizing radiation
Clinical Epigenetics (2024)
-
Extensive DNA methylome rearrangement during early lamprey embryogenesis
Nature Communications (2024)
-
DNA Methylation Analysis Reveals Potential Mechanism in Takifugu rubripes Against Cryptocaryon irritans Infection
Marine Biotechnology (2024)
-
Pan-cancer analysis revealed H3K4me1 at bivalent promoters premarks DNA hypermethylation during tumor development and identified the regulatory role of DNA methylation in relation to histone modifications
BMC Genomics (2023)
-
Epigenetics and stroke: role of DNA methylation and effect of aging on blood–brain barrier recovery
Fluids and Barriers of the CNS (2023)